Join to View Full Profile
4800 Sand Point Way NE 7420Seattle, WA 98105
Phone+1 206-987-2525
Fax+1 206-987-2649
Dr. Gust is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Child Neurology, 2014 - 2017- University of WashingtonResidency, Pediatrics, 2012 - 2014
- University of Washington School of MedicineClass of 2012
Certifications & Licensure
WA State Medical License 2017 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- Locoregional Infusion of EGFR806-CAR T Cells for Recurrent or Refractory Pediatric CNS Tumors: Results of the Completed BrainChild02 Phase 1 Clinical Trial.Juliane Gust, Bonnie L Cole, Rebecca Ronsley, Ashley L Wilson, Kristy Seidel
Neuro-Oncology. 2025-03-12 - 1 citationsIntracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe, Kristy Seidel, Wenjun Huang
Nature Medicine. 2025-03-01 - Cytokine-mediated increase in endothelial-leukocyte interaction mediates brain capillary plugging during CAR T cell neurotoxicity.Lina Park, Yu-Tung Tsai, Hyun-Kyoung Lim, Lila D Faulhaber, Katelyn Burleigh
Biorxiv. 2025-02-25
Press Mentions
- Does Neurofilament Light Chain Predict Neurotoxicity After CAR T-cell Infusion?October 27th, 2020
Grant Support
- Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated NeurotoxicitySEATTLE CHILDREN'S HOSPITAL2023–2028
- Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated NeurotoxicitySEATTLE CHILDREN'S HOSPITAL2023–2028
- Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated NeurotoxicitySEATTLE CHILDREN'S HOSPITAL2023–2028
- Brain Tumor CAR T Mouse ModelSEATTLE CHILDREN'S HOSPITAL2024–2026
- Brain Tumor CAR T Mouse ModelSEATTLE CHILDREN'S HOSPITAL2024–2026
- Brain Tumor CAR T Mouse ModelSEATTLE CHILDREN'S HOSPITAL2024–2026
- Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapySEATTLE CHILDREN'S HOSPITAL2020–2025
- Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapySEATTLE CHILDREN'S HOSPITAL2020–2025
- Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapySEATTLE CHILDREN'S HOSPITAL2020–2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
